Investment Pharmaceuticals

Wed, 09/23/2009 - 15:47

Nhwa Pharma to exit TCM industry

Shanghai. September 23. INTERFAX-CHINA - Shenzhen Stock Exchange-listed central nervous system (CNS) drug manufacturer Jiangsu Nhwa Pharmaceutical Co. Ltd. will transfer its entire 92.30 percent stake in Jiangsu Yihai Pharmaceutical Co. Ltd., a traditional Chinese medicine (TCM) manufacturer, to individual investor Chen Xiaoyi without consideration, it announced on Sept. 23.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW